USA - engelsk - NLM (National Library of Medicine)

golden state medical supply, inc. - ropinirole hydrochloride (unii: d7zd41rzi9) (ropinirole - unii:030pyr8953) - ropinirole 0.25 mg - ropinirole tablets are indicated for the treatment of parkinson’s disease. ropinirole tablets are indicated for the treatment of moderate-to-severe primary restless legs syndrome (rls). ropinirole tablets are contraindicated in patients known to have a hypersensitivity/allergic reaction (including urticaria, angioedema, rash, pruritus) to ropinirole or to any of the excipients. there are no adequate data on the developmental risk associated with the use of ropinirole tablets in pregnant women. in animal studies, ropinirole had adverse effects on development when administered to pregnant rats at doses similar to (neurobehavioral impairment) or greater than (teratogenicity and embryolethality at > 36 times) the mrhd for parkinson’s disease. ropinirole doses associated with teratogenicity and embryolethality in pregnant rats were associated with maternal toxicity. in pregnant rabbits, ropinirole potentiated the teratogenic effects of l-dopa when these drugs were administered in combination [see

USA - engelsk - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - ropinirole hydrochloride (unii: d7zd41rzi9) (ropinirole - unii:030pyr8953) - ropinirole 0.25 mg - ropinirole tablets are indicated for the treatment of parkinson’s disease. ropinirole tablets are indicated for the treatment of moderate-to-severe primary restless legs syndrome (rls). ropinirole tablets are contraindicated in patients known to have a hypersensitivity/allergic reaction (including urticaria, angioedema, rash, pruritus) to ropinirole or to any of the excipients. there are no adequate and well-controlled studies in pregnant women. in animal reproduction studies, ropinirole has been shown to have adverse effects on embryo-fetal development, including teratogenic effects. ropinirole should be used during pregnancy only if the potential benefit outweighs the potential risk to the fetus. oral treatment of pregnant rats with ropinirole during organogenesis resulted in decreased fetal body weight, increased fetal death, and digital malformations at 24, 36, and 60 times, respectively, the maximum recommended human dose (mrhd) for parkinson’s disease (24 mg/day) on a mg/m2 basis. the combined oral adm

USA - engelsk - NLM (National Library of Medicine)

apotex corp. - ropinirole hydrochloride (unii: d7zd41rzi9) (ropinirole - unii:030pyr8953) - ropinirole 0.25 mg - ropinirole tablets are indicated for the treatment of parkinson’s disease. ropinirole tablets are indicated for the treatment of moderate-to-severe primary restless legs syndrome (rls). ropinirole hydrochloride is contraindicated in patients known to have a hypersensitivity/allergic reaction (including urticaria, angioedema, rash, pruritus) to ropinirole or to any of the excipients. risk summary there are no adequate data on the developmental risk associated with the use of ropinirole hydrochloride in pregnant women. in animal studies, ropinirole had adverse effects on development when administered to pregnant rats at doses similar to (neurobehavioral impairment) or greater than (teratogenicity and embryolethality at >36 times) the maximum recommended human dose (mrhd) for parkinson’s disease. ropinirole doses associated with teratogenicity and embryolethality in pregnant rats were associated with maternal toxicity. in pregnant rabbits, ropinirole potentiated the teratogenic effects of l-dopa when these dr

Canada - fransk - Health Canada

teva canada limited - ropinirole (chlorhydrate de ropinirole) - comprimé - 0.25mg - ropinirole (chlorhydrate de ropinirole) 0.25mg - nonergot-derivative dopamine receptor agonists

Canada - fransk - Health Canada

teva canada limited - ropinirole (chlorhydrate de ropinirole) - comprimé - 1mg - ropinirole (chlorhydrate de ropinirole) 1mg - nonergot-derivative dopamine receptor agonists

Canada - fransk - Health Canada

teva canada limited - ropinirole (chlorhydrate de ropinirole) - comprimé - 2mg - ropinirole (chlorhydrate de ropinirole) 2mg - nonergot-derivative dopamine receptor agonists

Canada - fransk - Health Canada

teva canada limited - ropinirole (chlorhydrate de ropinirole) - comprimé - 5mg - ropinirole (chlorhydrate de ropinirole) 5mg - nonergot-derivative dopamine receptor agonists

Canada - fransk - Health Canada

dominion pharmacal - ropinirole (chlorhydrate de ropinirole) - comprimé - 5.0mg - ropinirole (chlorhydrate de ropinirole) 5.0mg - nonergot-derivative dopamine receptor agonists

Canada - fransk - Health Canada

pharmel inc - ropinirole (chlorhydrate de ropinirole) - comprimé - 0.25mg - ropinirole (chlorhydrate de ropinirole) 0.25mg - nonergot-derivative dopamine receptor agonists

Canada - fransk - Health Canada

pharmel inc - ropinirole (chlorhydrate de ropinirole) - comprimé - 0.5mg - ropinirole (chlorhydrate de ropinirole) 0.5mg - nonergot-derivative dopamine receptor agonists